首页 | 本学科首页   官方微博 | 高级检索  
检索        


Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1 mice
Authors:Joanna Riddoch-Contreras  Shi-Yu Yang  James RT Dick  Geoffrey Goldspink  Richard W Orrell  Linda Greensmith  
Institution:aSobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London WC1N 3BG, UK;bUniversity Department of Surgery, Royal Free and University College Medical School, UCL, Rowland Hill Street, London NW3 2PF, UK;cDepartment of Clinical Neuroscience, Institute of Neurology, UCL, Rowland Hill Street, London NW3 2PF, UK
Abstract:Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by motoneuron degeneration. Although viral delivery of IGF-I has shown therapeutic efficacy in the SOD1G93A mouse model of ALS, clinical trials of IGF-I in ALS patients have led to conflicting results. Here we examine the effects of an IGF-I splice variant, mechano-growth factor (MGF) which has previously been shown to have greater neuroprotective effects than IGF-I in a number of models of neurodegeneration. A mammalian expression plasmid containing either MGF or, for comparison, the IGF-I cDNA sequence was delivered to the hindlimb muscles of SOD1G93A mice at 70 days of age, at symptom onset. Treatment with either IGF-I or MGF resulted in a significant improvement in hindlimb muscle strength, and an increase in motor unit and motoneuron survival. Significantly more motoneurons survived in MGF treated mice.
Keywords:Neurotrophic factors  Motoneuron survival  Motor neuron disease  Therapy  Skeletal muscle  Neuroprotection  Amyotrophic lateral sclerosis  IGF-I  MGF
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号